Pierre Frange

Summary

Country: France

Publications

  1. ncbi Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, AP HP, Hopital Necker Enfants Malades, 149 rue de Sevres, 75015 Paris, France
    J Infect Dis 206:1269-74. 2012
  2. ncbi CCR5 antagonists: a therapeutic option in HIV-1 perinatally infected children experiencing virologic failure?
    Pierre Frange
    Université Paris Descartes EA 3620, Sorbonne Paris Cité, Paris, France
    AIDS 26:1673-7. 2012
  3. ncbi Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency
    Pierre Frange
    Universite Paris Descartes, Equipe d accueil 3620, Sorbonne Paris Cité, Paris, France
    PLoS ONE 7:e31695. 2012
  4. ncbi Adenoviral infection presenting as an isolated central nervous system disease without detectable viremia in two children after stem cell transplantation
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker Enfants Malades, 149 rue de Sevres, 75015 Paris, France
    J Clin Microbiol 49:2361-4. 2011
  5. ncbi Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Assistance Publique Hopitaux de Paris, Hopital Necker, Paris, France
    Pediatr Infect Dis J 30:684-8. 2011
  6. ncbi Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker, Paris, France
    AIDS 24:1771-6. 2010
  7. ncbi New and old complex recombinant HIV-1 strains among patients with primary infection in 1996-2006 in France: the French ANRS CO06 primo cohort study
    Pierre Frange
    EA 3620, Universite Paris Descartes, Laboratoire de Virologie, Hopital Necker Enfants Malades, AP HP, Paris, France
    Retrovirology 5:69. 2008
  8. ncbi Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO Cohort
    Julie Galimand
    Université Paris Descartes EA 3620, Paris, France
    AIDS Res Hum Retroviruses 26:645-51. 2010
  9. ncbi High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study
    Pierre Frange
    EA 3620, AP HP, Laboratoire de Virologie, Hopital Necker Enfants Malades, Universite Paris Descartes, Paris, France
    J Antimicrob Chemother 64:135-41. 2009
  10. ncbi Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection
    Pierre Frange
    Universitéé Paris Descartes, EA 3620, AP HP, Laboratoire de Virologie, Hopital Necker Enfants Malades, Paris, France
    J Clin Microbiol 48:3487-91. 2010

Collaborators

Detail Information

Publications19

  1. ncbi Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, AP HP, Hopital Necker Enfants Malades, 149 rue de Sevres, 75015 Paris, France
    J Infect Dis 206:1269-74. 2012
    ..1% of fecal samples were still positive after a median of 9.5-months follow-up. Further large longitudinal studies are needed to evaluate the clinical consequences of norovirus shedding in patients with primary immunodeficiencies...
  2. ncbi CCR5 antagonists: a therapeutic option in HIV-1 perinatally infected children experiencing virologic failure?
    Pierre Frange
    Université Paris Descartes EA 3620, Sorbonne Paris Cité, Paris, France
    AIDS 26:1673-7. 2012
    ..HIV-1 coreceptor usage was determined in HAART-failing children followed in Necker Hospital (Paris, France) in order to estimate the proportion of these patients who may benefit from CCR5-antagonists therapy...
  3. ncbi Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency
    Pierre Frange
    Universite Paris Descartes, Equipe d accueil 3620, Sorbonne Paris Cité, Paris, France
    PLoS ONE 7:e31695. 2012
    ..To analyse the contribution of primary human immunodeficiency virus type 1 (HIV-1) infection (PHI) to the French viral epidemic...
  4. ncbi Adenoviral infection presenting as an isolated central nervous system disease without detectable viremia in two children after stem cell transplantation
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker Enfants Malades, 149 rue de Sevres, 75015 Paris, France
    J Clin Microbiol 49:2361-4. 2011
    ....
  5. ncbi Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Assistance Publique Hopitaux de Paris, Hopital Necker, Paris, France
    Pediatr Infect Dis J 30:684-8. 2011
    ..Lopinavir/ritonavir (LPV/r) is now the protease inhibitor regimen of choice in the first-line antiretroviral therapy for children <6 years of age...
  6. ncbi Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker, Paris, France
    AIDS 24:1771-6. 2010
    ..To evaluate the risk of late postnatal HIV-1 infection in nonbreastfed children enrolled in the French ANRS Cohort CO01 (EPF)...
  7. ncbi New and old complex recombinant HIV-1 strains among patients with primary infection in 1996-2006 in France: the French ANRS CO06 primo cohort study
    Pierre Frange
    EA 3620, Universite Paris Descartes, Laboratoire de Virologie, Hopital Necker Enfants Malades, AP HP, Paris, France
    Retrovirology 5:69. 2008
    ..Our objective was to characterize in detail non-B strains which could not be genetically classified into the known subtypes/Circulating Recombinant Forms (CRFs)...
  8. ncbi Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO Cohort
    Julie Galimand
    Université Paris Descartes EA 3620, Paris, France
    AIDS Res Hum Retroviruses 26:645-51. 2010
    ....
  9. ncbi High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study
    Pierre Frange
    EA 3620, AP HP, Laboratoire de Virologie, Hopital Necker Enfants Malades, Universite Paris Descartes, Paris, France
    J Antimicrob Chemother 64:135-41. 2009
    ....
  10. ncbi Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection
    Pierre Frange
    Universitéé Paris Descartes, EA 3620, AP HP, Laboratoire de Virologie, Hopital Necker Enfants Malades, Paris, France
    J Clin Microbiol 48:3487-91. 2010
    ..Genotypic predictions can overestimate the proportion of non-subtype-B X4 viruses at PHI...
  11. ncbi Population pharmacokinetics of tenofovir in HIV-1-infected pediatric patients
    Naïm Bouazza
    EA 3620, Universite Paris Descartes, Sorbonne Paris Cité France, Paris, France
    J Acquir Immune Defic Syndr 58:283-8. 2011
    ..The main goal was then to suggest for the first time the dose of tenofovir disoproxil fumarate (TDF) to give in children...
  12. ncbi Pharmacokinetics and virological efficacy after switch to once-daily lopinavir-ritonavir in treatment-experienced HIV-1-infected children
    Frantz Foissac
    EA 3620 Université Paris Descartes, Paris, France
    Antimicrob Agents Chemother 55:4320-5. 2011
    ..The switch from the BID to the QD LPV/r regimen led to equivalent exposure and lower C(trough) values and resulted in lower levels of virological control in these antiretroviral-experienced children...
  13. ncbi [Chronic granulomatous disease: pathogenesis and therapy of associated fungal infections]
    ANNE DESJARDINS
    Service de Maladies Infectieuses et Tropicales, Hopital Necker Enfants Malades, Paris, France
    Med Sci (Paris) 28:963-9. 2012
    ..Here we review the genetic basis, pathogenesis and clinical presentation associated with fungal infections in chronic granulomatous disease as well as the current prophylaxis and newly available therapies...
  14. ncbi Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype
    Romain Micol
    CEREDIH, Hopital Necker Enfants Malades, Assistance Publique Hopitaux de Paris, 75743 Paris Cedex 15, France
    J Allergy Clin Immunol 128:382-9.e1. 2011
    ..The course of the disease is characterized by neurologic manifestations, infections, and cancers...
  15. ncbi Increasing HIV-1 Non-B Subtype Primary Infections in Patients in France and Effect of HIV Subtypes on Virological and Immunological Responses to Combined Antiretroviral Therapy
    Marie Laure Chaix
    Université Paris Descartes EA 3620, Sorbonne Paris Cité, Paris
    Clin Infect Dis 56:880-7. 2013
    ..Our results are encouraging for countries where non-B strains predominate in view of the increasing availability of cART...
  16. ncbi Developmental pharmacokinetics of lamivudine in 580 pediatric patients ranging from neonates to adolescents
    Naïm Bouazza
    EA 3620, Universite Paris Descartes, Paris, France
    Antimicrob Agents Chemother 55:3498-504. 2011
    ....
  17. ncbi Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients
    Monia Ouederni
    Pediatric Hematology Immunology Unit, Assistance Publique Hopitaux de Paris, Necker Hospital, France
    Blood 118:5108-18. 2011
    ..RFXANK deficiency is a severe, often fatal CID for which HSCT is the only curative treatment. However, some patients may survive for relatively long periods if multiple prophylactic measures are implemented...
  18. ncbi Characterization of an old complex circulating recombinant form, CRF27_cpx, originating from the Democratic Republic of Congo (DRC) and circulating in France
    Nicole Vidal
    UMR145, Institut de Recherches pour le Développement IRD and University of Montpellier 1, Montpellier, France
    AIDS Res Hum Retroviruses 24:315-21. 2008
    ..Continuous monitoring of HIV-1 strains thus remains important to allow early identification of the introduction of new variants...